Afobam is a brand name for alprazolam sold in Poland [1]. Alprazolam is a medication used to treat anxiety and panic disorders [2].
What is Afobam used for?
Afobam, containing the active ingredient alprazolam, is prescribed for the short-term management of generalized anxiety disorder, panic disorder, and anxiety associated with depression [2]. It works by calming the brain and nerves [2].
How does Afobam compare to other alprazolam brands?
Afobam is one of several brand names under which alprazolam is marketed. The active pharmaceutical ingredient, alprazolam, is the same across all brands, meaning their therapeutic effects are generally consistent. However, brand names can differ by manufacturer and country of origin. For instance, Xanax is a widely recognized global brand name for alprazolam, while Afobam is specifically for the Polish market [1]. Patients may sometimes encounter variations in inactive ingredients, which can occasionally affect tolerability for a small subset of individuals.
When does Afobam's patent expire in Poland?
Information regarding the specific patent expiration dates for Afobam in Poland is not publicly detailed here. Drug patent information is dynamic and often involves multiple patents covering the drug substance, formulation, and method of use, which can have different expiry dates. Resources like DrugPatentWatch.com track these details, but specific Polish patent expiry for Afobam would require a dedicated search on such platforms [3].
Can generic versions of Afobam be sold in Poland?
Once patents and any applicable market exclusivity periods expire, generic versions of alprazolam can be manufactured and sold in Poland. These generic products contain the same active ingredient as Afobam and are subject to strict regulatory approval to ensure they are bioequivalent and therapeutically interchangeable [4].
What are the side effects of Afobam?
Common side effects associated with alprazolam, the active ingredient in Afobam, include drowsiness, dizziness, fatigue, and coordination problems. Less common but more serious side effects can include memory problems, depression, and an increased risk of suicidal thoughts. It is crucial for patients to discuss any side effects experienced with their healthcare provider [2].
Where can I find more information on Afobam or alprazolam?
For detailed information on Afobam, including prescribing information and patient leaflets, consult the manufacturer's documentation or a healthcare professional. For broader insights into alprazolam's market, patent status, and regulatory landscape, resources like DrugPatentWatch.com can provide valuable data [3].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.nhs.uk/medicines/alprazolam/
[3] https://www.drugpatentwatch.com/
[4] https://www.ema.europa.eu/en/human-regulatory-information/medicines/generic-medicines